FDA approves first drug made from cannabis


The U.S. Food and Drug Administration approved the first-ever prescription drug made from marijuana Monday, The Associated Press reports. The medication, Epidiolex, is an oral treatment for seizures associated with two rare forms of childhood epilepsy. "This approval serves as a reminder that advancing sound development programs that properly evaluate active ingredients contained in marijuana can lead to important medical therapies," said the FDA commissioner, Scott Gottlieb.
Epidiolex uses cannabidiol (CBD), one of the chemicals in the cannabis plant, not tetrahydrocannabinol (THC), which causes the "high" associated with the drug.
"The difficult-to-control seizures that patients with Dravet syndrome and Lennox-Gastaut syndrome experience have a profound impact on these patients' quality of life," said Billy Dunn, the director of Division of Neurology Products at the FDA's research wing. "In addition to [Epidiolex being] another important treatment option for Lennox-Gastaut patients, this first-ever approval of a drug specifically for Dravet patients will provide a significant and needed improvement in the therapeutic approach to caring for people with this condition."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The medication, which comes in the form of a strawberry-flavored syrup from Britain's GW Pharmaceuticals, was tested in trials with more than 500 patients. Read about its common side effects and the approval process at the FDA's website.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Jeva Lange was the executive editor at TheWeek.com. She formerly served as The Week's deputy editor and culture critic. She is also a contributor to Screen Slate, and her writing has appeared in The New York Daily News, The Awl, Vice, and Gothamist, among other publications. Jeva lives in New York City. Follow her on Twitter.
-
5 cartoons about the TACO trade
Cartoons Political cartoonists take on America's tariffs, Vladimir Putin waiting for taco Tuesday, and a new presidential seal
-
A city of culture in the high Andes
The Week Recommends Cuenca is a must-visit for those keen to see the 'real Ecuador'
-
The Chagos Islands: Starmer's 'lousy deal'
Talking Point The PM's adherence to 'legalism' has given Mauritius a 'gift from British taxpayers'
-
Shakespeare not an absent spouse, study proposes
speed read A letter fragment suggests that the Shakespeares lived together all along, says scholar Matthew Steggle
-
New Mexico to investigate death of Gene Hackman, wife
speed read The Oscar-winning actor and his wife Betsy Arakawa were found dead in their home with no signs of foul play
-
Giant schnauzer wins top prize at Westminster show
Speed Read Monty won best in show at the 149th Westminster Kennel Club dog show
-
Beyoncé, Kendrick Lamar take top Grammys
Speed Read Beyoncé took home album of the year for 'Cowboy Carter' and Kendrick Lamar's diss track 'Not Like Us' won five awards
-
The Louvre is giving 'Mona Lisa' her own room
Speed Read The world's most-visited art museum is getting a major renovation
-
Honda and Nissan in merger talks
Speed Read The companies are currently Japan's second and third-biggest automakers, respectively
-
Taylor Swift wraps up record-shattering Eras tour
Speed Read The pop star finally ended her long-running tour in Vancouver, Canada
-
Drake claims illegal boosting, defamation
Speed Read The rapper accused Universal Music of boosting Kendrick Lamar's diss track and said UMG allowed him to be falsely accused of pedophilia